PrEP Works, But Only When You [Have Access to] Take it: Improving PrEP Access for Young People in Chicago and Philadelphia
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 1
Abstract
The 2012 United States Food and Drug Administration approval of Tenofovir/Emtricitabine for HIV pre-exposure prophylaxis (PrEP) has added a highly effective, safe biomedical option to the HIV prevention toolbox. In the United States, young black and Latino men who have sex with men (MSM) and transgender women are disproportionately affected by HIV risk over the course of their lifetime.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP353872
- DOI 10.23937/2469-567X/1510020
- Views 140
- Downloads 0
Dual Cytomegalovirus and Aspergillus Pneumonia Following Influenza B Infection in a Patient with Polyarteritis Nodosa
Polyarteritis Nodosa (PAN) is a systemic necrotizing vasculitis that might require immunosuppressive therapy. We report on a 72-year-old woman of PAN with influenza B infection, who developed dual cytomegalovirus and Asp...
p53 Expression Activation of HIV-1 Latency in U1 Cells
Latent infection is a major barrier for cure of HIV-1 infection. HIV-1 is capable of establishing latency when its host cells undergo apoptosis and initiate replication in response to this effect. HIV infection results i...
The AIDS Myth at 30
In 1985 the KGB and East Berlin's professor of Biology started the AIDS disinformation campaign by accusing the United States of America of having constructed and spread the AIDS agent in the course of biological weapons...
Determinants of Survival in HIV Patients: A Retrospective Study of Dilla University Hospital HIV Cohort
Introduction:Highly Active Antiretroviral Therapy (HAART) has remarkably improved the survival of Human Immunodeficiency Virus (HIV) patients though it is not sufficient alone to achieve better HIV related clinical outco...
The Monitoring of Lymphocyte Populations may be Optional in Patients with Suppressed Viremia: A Two Years Observational Study
The determination of lymphocyte populations (LPs) traditionally has been included in the routine follow-up of HIV-infected patients as an indicator of the degree of immune suppression and of the need to start treatment,...